Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
Mycotoxin produced by Aspergillus; BK K+ channe...
Endogenous pteridine metabolite of GTP.
Sulfonylurea; ATP-sensitive K+ channel blocker....
Iron chelator.
Thiazolidinedione; PPARγ agonist.
JAK3 and EGFR inhibitor.
A probe for cholesterol in biological membranes...
Synthetic peptice; μOR agonist.
AhR agonist.
GABA-A antagonist.
GnRH analog; GnRH1 agonist.
Docetaxel impurity
Curcumin derivative.
Cysteine protease inhibitor.
Bone deterioration inhibitor, potential CaR ago...
Synthetic non-steroid endocrine disrupter; ER a...
Thio sulforaphane analog, ITC.
ITC found in cruciferous vegetables, homolog of...
Citalopram analog